The relevant information included in this section is exactly as published on the website of the National Securities Market Commission (CNMV)
Filter results
| Date | Title | Content | |
|---|---|---|---|
| 9/07/2020 | On business and financial situation | ROVI informs on the Collaboration with Moderna for Outside the United States Fill-Finish Manufacturing of Moderna’s COVID-19 Vaccine Candidate | |
| 2/07/2020 | Liquidity contracts and specialists | Liquidity contract: transactions conducted in the second quarter of 2020 | |
| 13/05/2020 | On business and financial situation | ROVI releases the presentation related to the first quarter 2020 financial results | |
| 13/05/2020 | Interim Management Report | The company releases the press release related to the 2020 first quarter financial results | |
| 13/05/2020 | Announcement of general shareholders’ meeting | ROVI releases the information related to its 2020 General Shareholders Meeting | |
| 2/04/2020 | On business and financial situation | ROVI informs on the impact of Covid‑19 on the company’s activities | |
| 2/04/2020 | Liquidity contracts and specialists | Liquidity contract: transactions conducted in the first quarter of 2020 | |
| 26/02/2020 | Information on P&L | ROVI releases the full year 2019 results presentation | |
| 26/02/2020 | Annual Report regarding remuneration of the members of the Board of Directors | ROVI releases the 2019 annual report regarding remuneration of the members of the Board of Directors | |
| 26/02/2020 | Information on P&L | ROVI releases the press release related to the full year 2019 financial results |